Nan Chi Wan - Concepedia

Concepedia

Author

Nan Chi Wan

General Hospital of Shenyang Military Region ORCID

Also Known As

Lu Wang, N. C. WAN, N. C. Wan, N.C. Wan, Nan Chi Wan, Nan Wan, Wan, N.C., Wan, Nan Chi

48

Publications

1.8K

Citations

13

H-Index

45

Concepts

All Affiliations

General Hospital of Shenyang Military Region Beijing Radiation Center Hong Kong University of Science and Technology Cancer Research UK Institute of Cancer Research

NC

About

Nan Chi Wan is an author at General Hospital of Shenyang Military Region specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Biochemistry	4	4	231
3	Natural Sciences	3	3	143
4	Engineering	1	1	29
5	Public Health	1	1	11

Nan Chi Wan

×

15

Publications

1.8K

Citations

13

H-Index

	Year	Citations
The Identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer Adrian Folkes, Khatereh Ahmadi, W. Alderton, Journal of Medicinal Chemistry Pi3 KinaseChemoprevention StrategyPharmacotherapyPharmaceutical ChemistryTumor Biology	2008	739
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941 Florence I. Raynaud, Suzanne A. Eccles, Sonal Patel, Molecular Cancer Therapeutics	2009	270
Dual-recognition surface-enhanced Raman scattering(SERS)biosensor for pathogenic bacteria detection by using vancomycin-SERS tags and aptamer-Fe3O4@Au Yuanfeng Pang, Nan Chi Wan, Luoluo Shi, Analytica Chimica Acta Pathogen DetectionVancomycin-sers TagsPathogenic Bacteria DetectionSurface-enhanced Raman ScatteringMicrobiology	2019	181
Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer Daniel P. Sutherlin, Deepak Sampath, Megan Berry, Journal of Medicinal Chemistry	2010	131
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor Timothy P. Heffron, Megan Berry, Georgette M. Castanedo, Bioorganic & Medicinal Chemistry Letters BiochemistryG Protein-coupled ReceptorMedicineFunctional SelectivityMechanism Of Action	2010	88
Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform Timothy P. Heffron, BinQing Wei, Alan G. Olivero, Journal of Medicinal Chemistry Peptide ScienceChemical BiologyExhibit SelectivityMolecular PharmacologyMedicinal Chemistry	2011	70
Development of spike protein-based fluorescence lateral flow assay for the simultaneous detection of SARS-CoV-2 specific IgM and IgG Chongwen Wang, Dawei Shi, Nan Chi Wan, The Analyst	2021	54
Design and Synthesis of New Templates Derived from Pyrrolopyrimidine as Selective Multidrug-Resistance-Associated Protein Inhibitors in Multidrug Resistance Shouming Wang, Nan Chi Wan, John Harrison, Journal of Medicinal Chemistry Combinatorial ChemistryNovel TemplatesMultidrug ResistancePharmacotherapyPharmaceutical Chemistry	2004	44
Lithium Ephedrinate Mediated Aldol Reaction of Arylacetonitriles: Thermodynamic Control of Enantioselectivity Paul R. Carlier, Weldon W.-F. Lam, Nan Chi Wan, Angewandte Chemie International Edition	1998	34
Scale-Up of a High Cell Density Continuous Culture with Pichia pastoris X-33 for the Constitutive Expression of rh-Chitinase B. M. Schilling, Jason C. Goodrick, Nan Chi Wan Biotechnology Progress	2001	33

Page 1